EC Number |
Inhibitors |
Structure |
---|
7.2.2.13 | (3beta,12beta,20R)-12-hydroxy-3-phenoxy-20,25-epoxydammaran-6-one |
- |
|
7.2.2.13 | (3beta,12beta,20R)-12-hydroxy-3-[(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)oxy]-20,25-epoxydammaran-6-one |
- |
|
7.2.2.13 | (3beta,12beta,20R)-12-hydroxy-3-[4-(trifluoromethoxy)phenoxy]-20,25-epoxydammaran-6-one |
- |
|
7.2.2.13 | (3beta,12beta,20R)-3-(ethenyloxy)-12-hydroxy-20,25-epoxydammaran-6-one |
- |
|
7.2.2.13 | (3beta,12beta,20R)-3-ethoxy-12-hydroxy-20,25-epoxydammaran-6-one |
- |
|
7.2.2.13 | (3E,5beta,15beta,16beta)-16-(acetyloxy)-3-(hydroxyimino)-8-methyl-14,15-epoxybufa-20,22-dienolide |
- |
|
7.2.2.13 | (3E,5beta,15beta,16beta)-16-(acetyloxy)-3-(methoxyimino)-8-methyl-14,15-epoxybufa-20,22-dienolide |
- |
|
7.2.2.13 | (3E,5beta,15beta,16beta)-16-(acetyloxy)-3-[(2-aminoethoxy)imino]-8-methyl-14,15-epoxybufa-20,22-dienolide |
most potent inhibitor |
|
7.2.2.13 | (5aR,7R,8S,10aR,10bR)-7-hydroxy-1,1,5a,10a,10b-pentamethyl-8-[(2R)-2,6,6-trimethyloxan-2-yl]hexadecahydrocyclopenta[5,6]naphtho[2,1-c]azepine-3,12-dione |
- |
|
7.2.2.13 | (5aR,8S,10aR,10bR,12R)-12-hydroxy-1,1,5a,10a,10b-pentamethyl-8-[(2R)-2,6,6-trimethyloxan-2-yl]tetradecahydro-1H-cyclopenta[5,6]naphtho[2,1-c]oxepine-3,7-dione |
- |
|